Single-dose antibiotic prevents maternal sepsis and death

On February 9, 2023  at 01:15 PM EST the NIH announced that a single oral dose of the antibiotic azithromycin can lower the risk of postpartum sepsis and death among females who deliver vaginally by one-third, according to a large multi-country clinical trial funded by the National Institutes of Health.
Just 1.6% of females in the study who received azithromycin during labor developed sepsis or passed away within six weeks after delivering their infants, compared to 2.4% of those women who received a placebo.

Azithromycin did not lessen the risk of newborn sepsis, stillbirth, or newborn death.
Azithromycin is a medicine used for the treatment of numerous bacterial infections

Click the link to learn more, Single-dose antibiotic prevents maternal sepsis and death02/09/2023 01:15 PM EST

By Anita Johnson-Brown

More News from Los Angeles

• News Mix Top News
• Anita Brown's commentary Opinions matter